Skip to content
Trial Eligibility
Menu

Cannabis' Impact on Alcohol Consumption

NCT05389930

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo. The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Alcohol Drinking
  • Cannabis Use
  • Cannabis
  • Alcohol Use Disorder

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2
Ages
21 to 50 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Brown University
Last updated on ClinicalTrials.gov
October 5, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Rhode Island · 1

  • Brown University · Providence, RI

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.